missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. Novus Biologicals™ PRAME Antibody (PRAME/9188), Novus Biologicals™
  7. 30043309

Novus Biologicals™ PRAME Antibody (PRAME/9188), Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals™ NBP3-26783-100ug

 View more versions of this product

Product Code. 30043309

  • 486.00 € / 100µg

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

PRAME Monoclonal antibody specifically detects PRAME in Human samples. It is validated for Immunohistochemistry (Paraffin)
TRUSTED_SUSTAINABILITY
Specifications

Specifications

PRAME
Monoclonal
0.2 mg/mL
Immunohistochemistry-Paraffin 1-2 μg/mL for 30 minutes at RT
cancer/testis antigen 130, MAPEOIP4CT130, melanoma antigen preferentially expressed in tumors, OIP-4, Opa-interacting protein 4, Opa-interacting protein OIP4, preferentially expressed antigen in melanoma, Preferentially expressed antigen of melanoma
Recombinant fragment (around aa100-250) of human PRAME protein (exact sequence is proprietary)
100 μg
Cancer
23532
Store at 4°C.
IgG2b κ
Immunohistochemistry (Paraffin)
PRAME/9188
Unconjugated
10 mM PBS with 0.05% BSA
Mouse
Protein A or G purified
RUO
Primary
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.